Clinical Trial Update: A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in Portugal

View source ↗

Summary

A completed study in Portugal evaluating how paliperidone palmitate affects clinical outcomes and hospital resource use in adults with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone palmitate (Paliperidone palmitate)

Snippet

Sponsor: Janssen-Cilag Farmaceutica Ltda. | Conditions: Schizophrenia | Status: COMPLETED